Rothwell Investment Advisors, LLC’s Medifast MED Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$28	Buy	+2	New	+$23	﹤0.01%	1124

Other funds holding MED

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return

Lido Advisors Los Angeles, California $39.1B AUM 20.96% 1-Year Est. Return

Commons Capital Needham, Massachusetts $148M AUM 27.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Virtus Family Office El Paso, Texas $131M AUM 16.07% 1-Year Est. Return

Great Lakes Advisors Chicago, Illinois $12.7B AUM 28.72% 1-Year Est. Return

Littlejohn Financial Services Roseburg, Oregon $135M AUM 16.01% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Rothwell Investment Advisors, LLC's MED Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Medifast (MED) in Q3 2026: 2 shares worth $28. The stake represents ﹤0.01% of the portfolio and ranks #1124 among its holdings.

29 funds tracked by Wall St. Rank hold MED as of Q3 2026.

Rothwell Investment Advisors, LLC held 2 shares of Medifast worth $28 as of Q3 2026.
Medifast was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Medifast made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #1124 holding.
29 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.